Product Program year 2025 Source: CMS Open Payments

Vis-Rx

Device Vascular Imaging

PDI 00859910007018

Open in the dashboard

General payments

$427,959

189 payments

Research payments

$1,043,560

93 payments

Through program year 2025, $427,959 in general payments and $1,043,560 in research payments were reported against Vis-Rx (Vascular Imaging).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Amount Payments
2025 General $71,927 21
2025 Research $141,623 18
2024 General $144,284 68
2024 Research $326,786 28
2023 General $110,578 61
2023 Research $357,446 29
2022 General $97,695 34
2022 Research $182,223 13
2021 General $3,475 5
2021 Research $35,482 5

Breakdown

Who paid General payments · program years 2021–2025
  1. Gentuity, LLC $427,959 189 payments
Top recipients General payments · program year 2025
  1. Hiram Bezerra Cardiovascular Disease · Tampa, FL $60,262 84% · 8 payments
  2. Eric Osborn Interventional Cardiology · Boston, MA $6,500 9% · 1 payment
  3. Ryan Madder Interventional Cardiology · Royal Oak, MI $2,806 4% · 3 payments
  4. Matthew Price Interventional Cardiology · La Jolla, CA $1,200 2% · 1 payment
  5. Uh Cleveland Medical Center Teaching hospital · OH $277 <1% · 1 payment

The top 5 of 10 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Cardiovascular Disease Internal Medicine $60,262 84% · 1 practitioner
  2. Interventional Cardiology Internal Medicine $11,205 16% · 7 practitioners
  3. Nurse Practitioner $183 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Florida $60,360 84% · 2 recipients
  2. Massachusetts $6,500 9% · 1 recipient
  3. Michigan $2,806 4% · 1 recipient
  4. California $1,200 2% · 1 recipient
  5. Ohio $852 1% · 4 recipients

The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

189 general · 93 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record